Zenith TX2 Pro-Form G53451Recalls & reported problems
William Cook Europe ApS · Zenith TX2, TAA Endovascular Graft with Pro-Form, Proximal Tapered Component · Class 3 · Implant
All models of Zenith TX2 Pro-Form (15)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 4
- Deaths reported
- 1
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 10827002534510), received between May 27, 2016 and Apr 16, 2020 — classified as 1 death, 1 injury, 2 malfunctions.
The most frequently reported specific device problem is “Break” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
- Break1
- Difficult or Delayed Positioning1
- Flaked1
- Inadequacy of Device Shape and/or Size1
- Leak/Splash1
- Migration or Expulsion of Device1
Patient problems
- No Consequences Or Impact To Patient2
- Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available1
- Cardiac Arrest1
- Death1
- Hemorrhage/Blood Loss/Bleeding1
- Multiple Organ Dysfunction Syndrome1
- No Code Available1
- No Known Impact Or Consequence To Patient1
Recent adverse event reports
The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.
MalfunctionApr 16, 2020Inadequacy of Device Shape and/or Size; Adverse Event Without Identified Device or Use Problem; Inadequacy of Device Shape and/or Size; Adverse Event Without Identified Device or Use Problem
DESCRIPTION OF EVENT ACCORDING TO STUDY: GRAFT KINK. ON (B)(6) 2015, THE PATIENT RECEIVED A ZTEG-2PT-40-208-PF-US. THERE WERE NO DIFFICULTIES DEPLOYING THE DEVICE. A MOLDING BALLOON WAS NOT USED. NO PATIENT-RELATED ADVERSE EVENTS WERE OBSERVED DURING THE PROCEDURE. PER SITE AND ANALYSIS, THE DEVICE WAS PATENT WITH NO KINK OR ENDOLEAK ON THE COMPLETION ANGIOGRAM. THE PATIENT WAS DISCHARGED FROM THE HOSPITAL ON (B)(6) 2015 (THREE DAYS POST-PROCEDURE). (B)(6) 2015 CT SCAN (40 DAYS POST-PROCEDURE): ANALYSIS: GRAFT PATENT AND INTACT WITH NO KINK OR ENDOLEAK. ANEURYSM DIAMETER = 77.7 MM. (B)(6) 2015 CT SCAN (185 DAYS POST-PROCEDURE): ANALYSIS: GRAFT PATENT AND INTACT WITH NO MIGRATION, KINK, OR ENDOLEAK. ANEURYSM DIAMETER = 67.9 MM. ANALYSIS ALSO NOTED < 1 CM DISTAL SEAL ZONE. (B)(6) 2016 CT SCAN (381 DAYS POST-PROCEDURE): CRANIAL MIGRATION AND UNKNOWN ENDOLEAK ((B)(4)). (B)(6) 2020 ANALYSIS REVIEW OF A CT PERFORMED ON (B)(6) 2019 REVEALED A PATENT AND INTACT GRAFT WITH NO ENDOLEAK PRESENT. A KINK WAS IDENTIFIED AND THE LOCATION WAS NOTED AS, ¿DISTAL AORTIC ARCH/PROXIMAL DESCENDING THORACIC AORTA.¿ ANALYSIS ALSO NOTED THE FOLLOWING, ¿AT 48 MONTHS, THERE WAS VERY EARLY NARROWING OF THE DE
Patient problems: Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available; No Consequences Or Impact To Patient
MAUDE report 9966547 ↗DeathAug 28, 2017Flaked; Flaked
DESCRIPTION OF EVENT ACCORDING TO INITIAL REPORTER: "ON A MEETING ON MONDAY, PHYSICIAN INDICATED HE HAD A PATIENT THAT UNDERWENT A PROCEDURE AND DIED A FEW DAYS POST OP FROM MULTI-ORGAN FAILURE. AUTOPSY DETERMINED SOME OF THE HYDROPHILLIC COATING IN THE ORGANS, ASSUMED FROM THE DELIVERY SYSTEM." PATIENT OUTCOME: PT IS DECEASED.
Patient problems: Cardiac Arrest; Death; Multiple Organ Dysfunction Syndrome; Paraplegia
MAUDE report 6823343 ↗InjuryJul 13, 2016Leak/Splash; Migration or Expulsion of Device; Migration or Expulsion of Device
DESCRIPTION OF EVENT ACCORDING TO STUDY: ON (B)(6) 2015, THE PATIENT RECEIVED A ZTEG-2PT-40-208-PF-US (LOT # E3209058). THERE WERE NO DIFFICULTIES DEPLOYING THE DEVICE. A MOLDING BALLOON WAS NOT USED. NO PATIENT-RELATED ADVERSE EVENTS WERE OBSERVED DURING THE PROCEDURE. THE DEVICE WAS PATENT WITH NO KINK OR ENDOLEAK ON THE COMPLETION ANGIOGRAM. THE PATIENT WAS DISCHARGED FROM THE HOSPITAL ON (B)(6) 2015 (THREE DAYS POST-PROCEDURE). THE (B)(6) 2015 CT SCAN (40 DAYS POST-PROCEDURE): ANALYSIS REVIEW: GRAFT PATENT AND INTACT WITH NO KINK OR ENDOLEAK ANEURYSM DIAMETER = 77.7 MM. THE (B)(6) 2015 CT SCAN (185 DAYS POST-PROCEDURE): ANALYSIS REVIEW: GRAFT PATENT AND INTACT WITH NO MIGRATION, KINK, OR ENDOLEAK. ANEURYSM DIAMETER = 67.9 MM. IT WAS ALSO NOTED < 1 CM DISTAL SEAL ZONE. THE (B)(6) 2016 CT SCAN (381 DAYS POST-PROCEDURE): ANALYSIS REVIEW: GRAFT PATENT AND INTACT WITH NO MIGRATION OR KINK. A DISTAL TYPE I ENDOLEAK WAS NOTED. ANEURYSM DIAMETER = 63.8 MM. ANALYSIS MADE THE FOLLOWING COMMENT: ¿THE DISTAL SEAL MAY BE COMPROMISED BY AN INCREASE IN AORTA DIAMETER. THERE IS A SEGMENT OF SEAL AT THE MID-GRAFT LEVEL, EXTENDING JUST UNDER 10MM, THAT APPEARS TO BE ALLOWING THE PRIMARY PORTION
Patient problems: Hemorrhage/Blood Loss/Bleeding; No Code Available
MAUDE report 5788637 ↗MalfunctionMay 27, 2016Break; Difficult or Delayed Positioning; Difficult or Delayed Positioning
DESCRIPTION OF EVENT ACCORDING TO COMPLAINANT: UPON DEPLOYMENT, IT WAS VERY DIFFICULT TO RELEASE THE TRIGGER WIRES. WIRES WERE ABLE TO BE RELEASED INDIVIDUALLY WITH HEMOSTAT. DUE TO MANIPULATION REQUIRED ONE OF THE NITINOL WIRES BROKE. ULTIMATELY, THE PROCEDURE WAS SUCCESSFUL AND THE DEVICE WAS PLACED IN THE PATIENT. PATIENT OUTCOME: THE PATIENT DID NOT REQUIRE ANY ADDITIONAL PROCEDURES DUE TO THIS OCCURRENCE. ACCORDING TO THE INITIAL REPORTER, THE PATIENT DID NOT EXPERIENCE ANY ADVERSE EFFECTS DUE TO THIS OCCURRENCE.
Patient problems: No Consequences Or Impact To Patient; No Known Impact Or Consequence To Patient
MAUDE report 5684257 ↗
Other SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page